Form 424B5 Niagen Bioscience, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/27/2026
- Wall St climbs after US, Iran pause conflict; focus on Fed, earnings
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Why is Bernstein bullish on memory stocks after Samsung, Nvidia deals?
- Oil prices near one-week low after US, Iran pause fighting over weekend
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- Taiwan Semi (TSM) PT Raised to $530 at Needham
- Strategy sells MSTR shares, doesn't buy bitcoin
Niagen Bioscience files to sell up to $50M in common stock
July 10, 2026 5:08 PM EDTNiagen Bioscience (NASDAQ: NAGE) has filed to offer up to $50,000,000 in common stock through a sales agreement dated June 26, 2026, with Canaccord Genuity LLC and Roth Capital Partners, LLC acting as sales agents.
Under the terms of the agreement, the company... More
